UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)

BMC cancer, 2024-01, Vol.24 (1), p.91-91, Article 91

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma

Cancer chemotherapy and pharmacology, 2022-02, Vol.89 (2), p.255-265

2022

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.269-283

2021

Link zum Volltext

Verfügbarkeit prüfen

Can 18F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?

Cancers, 2022-06, Vol.14 (12), p.3035

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland

Current oncology (Toronto), 2024-03, Vol.31 (3), p.1302-1310

2024

Link zum Volltext

Verfügbarkeit prüfen

Metastatic medullary thyroid carcinoma presenting as ectopic Cushing’s syndrome

Endocrinology, diabetes & metabolism case reports, 2021-04, Vol.2021 (1), p.1-5

2021

Link zum Volltext

Verfügbarkeit prüfen

Optimal management of gastroesophageal junction cancer

Cancer, 2019-06, Vol.125 (12), p.1990-2001

2019

Link zum Volltext

Verfügbarkeit prüfen

HER2: An emerging target in colorectal cancer

Current problems in cancer, 2018-11, Vol.42 (6), p.560-571

2018

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant therapy for esophageal cancer: Who, when, and what?

Cancer, 2018-11, Vol.124 (22), p.4276-4278

2018

Link zum Volltext

Verfügbarkeit prüfen

Duration of Adjuvant Chemotherapy in Colon Cancer: Current Standards and New Updates

Current colorectal cancer reports, 2019-08, Vol.15 (4), p.122-129

2019

Link zum Volltext

Verfügbarkeit prüfen

A survey of colorectal cancer (CRC) survivorship practices in Ireland, and implementation of a survivorship care plan (SCP) pilot program

Journal of clinical oncology, 2018-03, Vol.36 (7_suppl), p.60-60

2018

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy (AC) for stage III colorectal cancer (CRC) in the elderly: An Irish experience

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.54-54

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer

Clinical cancer research, 2019-10, Vol.25 (20), p.6160-6169

2019

Link zum Volltext

Verfügbarkeit prüfen

Actionable alterations (AA) in gastrointestinal (GI) cancers: Rate of detection and receipt of matched therapies (MT)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15677-e15677

2020

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant trastuzumab deruxtecan

BMC cancer, 2024-01, Vol.24 (1)

2024

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitors in esophagogastric adenocarcinoma: do the results justify the hype?

Journal of thoracic disease, 2018-12, Vol.10 (12), p.6407-6411

2018

Link zum Volltext

Verfügbarkeit prüfen

Comment on "Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric Cancer": Are we There Yet?

Annals of surgery, 2019-08, Vol.270 (2), p.e39

2019

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy for poor pathologic response after pre-operative chemoradiation in esophageal cancer: infeasible and illogical

Journal of thoracic disease, 2019-09, Vol.11 (Suppl 15), p.S1855-S1860

2019

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific membrane antigen (PSMA) PET-CT imaging in the investigation and management of biochemical recurrence in prostate cancer

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.208-208

2018

Link zum Volltext

Verfügbarkeit prüfen

Examination of the functional and diagnostic potential of methylation-sensitive enhancers in metastatic colorectal cancer

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.TPS237-TPS237

2022

Link zum Volltext

Verfügbarkeit prüfen

Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric Cancer: Are we There Yet?

Annals of surgery, 2018-11, p.1

2018

Link zum Volltext

Verfügbarkeit prüfen

Mucinous colorectal cancer: Disease characteristics, treatment outcomes and the impact of metastasectomy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3586-3586

2021

Link zum Volltext

Verfügbarkeit prüfen

Total neoadjuvant chemo (ctx; TNT) for locally advanced gastric cancer (GC): The Memorial Sloan Kettering Cancer Center experience

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4046-4046

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4047-4047

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase I/Ib study of crenolanib with ramucirumab (RAM)/paclitaxel (PTX) as second-line therapy (2L tx) for advanced esophagogastric adenocarcinoma (EGA)

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.116-116

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Oncology
(17)
Humans
(13)
Female
(9)
Medicine
(8)
Medicine & Public Health
(8)
Chemotherapy
(7)
Male
(7)
Adult
(6)
Esophageal Cancer
(6)
Treatment Outcome
(6)
Aged
(5)
Internal Medicine
(5)
Middle Aged
(5)
Adenocarcinoma
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Biomarkers
(4)
Breast Cancer
(4)
Chemoradiation
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)

Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma

Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study

Can 18F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?

Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland

Metastatic medullary thyroid carcinoma presenting as ectopic Cushing’s syndrome

Optimal management of gastroesophageal junction cancer

HER2: An emerging target in colorectal cancer

Neoadjuvant therapy for esophageal cancer: Who, when, and what?

Duration of Adjuvant Chemotherapy in Colon Cancer: Current Standards and New Updates

A survey of colorectal cancer (CRC) survivorship practices in Ireland, and implementation of a survivorship care plan (SCP) pilot program

Adjuvant chemotherapy (AC) for stage III colorectal cancer (CRC) in the elderly: An Irish experience

Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer

Actionable alterations (AA) in gastrointestinal (GI) cancers: Rate of detection and receipt of matched therapies (MT)

Neoadjuvant trastuzumab deruxtecan

Immune checkpoint inhibitors in esophagogastric adenocarcinoma: do the results justify the hype?

Comment on "Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric Cancer": Are we There Yet?

Adjuvant chemotherapy for poor pathologic response after pre-operative chemoradiation in esophageal cancer: infeasible and illogical

Prostate-specific membrane antigen (PSMA) PET-CT imaging in the investigation and management of biochemical recurrence in prostate cancer

Examination of the functional and diagnostic potential of methylation-sensitive enhancers in metastatic colorectal cancer

Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric Cancer: Are we There Yet?

Mucinous colorectal cancer: Disease characteristics, treatment outcomes and the impact of metastasectomy

Total neoadjuvant chemo (ctx; TNT) for locally advanced gastric cancer (GC): The Memorial Sloan Kettering Cancer Center experience

Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy

A phase I/Ib study of crenolanib with ramucirumab (RAM)/paclitaxel (PTX) as second-line therapy (2L tx) for advanced esophagogastric adenocarcinoma (EGA)

Suchergebnisse filtern